Scott Stroup

Summary

Affiliation: University of North Carolina
Country: USA

Publications

  1. ncbi request reprint Decision-making capacity for research participation among individuals in the CATIE schizophrenia trial
    Scott Stroup
    Department of Psychiatry, University of North Carolina at Chapel Hill, CB 7160, Chapel Hill, NC 27599 7160, USA
    Schizophr Res 80:1-8. 2005
  2. pmc Results of phase 3 of the CATIE schizophrenia trial
    T Scott Stroup
    Department of Psychiatry, School of Medicine, University of North Carolina at Chapel Hill, USA
    Schizophr Res 107:1-12. 2009
  3. pmc Randomized controlled trials for schizophrenia: study designs targeted to distinct goals
    T Scott Stroup
    Department of Psychiatry, University of North Carolina, Chapel Hill, NC 27599 7160, USA
    Schizophr Bull 34:266-74. 2008
  4. ncbi request reprint Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic
    T Scott Stroup
    Department of Psychiatry, University of North Carolina at Chapel Hill, CB 7160, Chapel Hill, NC 27599 7160, USA
    Am J Psychiatry 163:611-22. 2006
  5. ncbi request reprint Clinical trials for antipsychotic drugs: design conventions, dilemmas and innovations
    T Scott Stroup
    Department of Psychiatry, University of North Carolina at Chapel Hill, CB 7160, Chapel Hill, North Carolina 27599 7160, USA
    Nat Rev Drug Discov 5:133-46. 2006
  6. pmc Evaluation of "subject advocate" procedures in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia study
    T Scott Stroup
    Department of Psychiatry, University of North Carolina School of Medicine, University of North Carolina at Chapel Hill, CB 7160, Chapel Hill, NC 27599 7160, USA
    Schizophr Bull 32:147-52. 2006
  7. ncbi request reprint Practical clinical trials for schizophrenia
    Scott Stroup
    Epidemiol Psichiatr Soc 14:132-6. 2005
  8. ncbi request reprint The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2003 update
    Alexander L Miller
    Department of Psychiatry, The University of Texas Health Science Center at San Antonio, MC 7792, 7703 Floyd Curl Drive, San Antonio, TX 78229 3900, USA
    J Clin Psychiatry 65:500-8. 2004
  9. doi request reprint Science and recovery in schizophrenia
    Jeffrey A Lieberman
    Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, NY, USA
    Psychiatr Serv 59:487-96. 2008
  10. ncbi request reprint Atypical and conventional antipsychotic drugs in treatment-naive first-episode schizophrenia: a 52-week randomized trial of clozapine vs chlorpromazine
    Jeffrey A Lieberman
    Department of Psychiatry, CB 7160, University of North Carolina School of Medicine, Chapel Hill, NC 27599 7160, USA
    Neuropsychopharmacology 28:995-1003. 2003

Research Grants

  1. Addressing Challenges in Schizophrenia Research
    THOMAS STROUP; Fiscal Year: 2007

Detail Information

Publications12

  1. ncbi request reprint Decision-making capacity for research participation among individuals in the CATIE schizophrenia trial
    Scott Stroup
    Department of Psychiatry, University of North Carolina at Chapel Hill, CB 7160, Chapel Hill, NC 27599 7160, USA
    Schizophr Res 80:1-8. 2005
    ....
  2. pmc Results of phase 3 of the CATIE schizophrenia trial
    T Scott Stroup
    Department of Psychiatry, School of Medicine, University of North Carolina at Chapel Hill, USA
    Schizophr Res 107:1-12. 2009
    ..We describe the characteristics of the patients who selected each treatment option and their outcomes...
  3. pmc Randomized controlled trials for schizophrenia: study designs targeted to distinct goals
    T Scott Stroup
    Department of Psychiatry, University of North Carolina, Chapel Hill, NC 27599 7160, USA
    Schizophr Bull 34:266-74. 2008
    ..The different objectives of trials should be considered in the interpretation of the complete body of randomized evidence on antipsychotic drugs...
  4. ncbi request reprint Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic
    T Scott Stroup
    Department of Psychiatry, University of North Carolina at Chapel Hill, CB 7160, Chapel Hill, NC 27599 7160, USA
    Am J Psychiatry 163:611-22. 2006
    ..This randomized, double-blind study compared olanzapine, quetiapine, risperidone, and ziprasidone in patients who had just discontinued a different atypical antipsychotic...
  5. ncbi request reprint Clinical trials for antipsychotic drugs: design conventions, dilemmas and innovations
    T Scott Stroup
    Department of Psychiatry, University of North Carolina at Chapel Hill, CB 7160, Chapel Hill, North Carolina 27599 7160, USA
    Nat Rev Drug Discov 5:133-46. 2006
    ..Practical and large, simple trials that evaluate the comparative effectiveness of antipsychotic drugs in real-world settings can help to meet these needs once a drug has reached the market...
  6. pmc Evaluation of "subject advocate" procedures in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia study
    T Scott Stroup
    Department of Psychiatry, University of North Carolina School of Medicine, University of North Carolina at Chapel Hill, CB 7160, Chapel Hill, NC 27599 7160, USA
    Schizophr Bull 32:147-52. 2006
    ..Nonspecific benefits included good public relations and engagement of family members. Improved training regarding the procedures may be needed to achieve specific goals of enhanced patient autonomy and retention in the study...
  7. ncbi request reprint Practical clinical trials for schizophrenia
    Scott Stroup
    Epidemiol Psichiatr Soc 14:132-6. 2005
  8. ncbi request reprint The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2003 update
    Alexander L Miller
    Department of Psychiatry, The University of Texas Health Science Center at San Antonio, MC 7792, 7703 Floyd Curl Drive, San Antonio, TX 78229 3900, USA
    J Clin Psychiatry 65:500-8. 2004
    ..This article reports the recommendations developed in 2002 and 2003 by a group of experts, clinicians, and administrators...
  9. doi request reprint Science and recovery in schizophrenia
    Jeffrey A Lieberman
    Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, NY, USA
    Psychiatr Serv 59:487-96. 2008
    ..Future clinical and neuroscience research and service development should emphasize measures of recovery as outcomes for people with schizophrenia...
  10. ncbi request reprint Atypical and conventional antipsychotic drugs in treatment-naive first-episode schizophrenia: a 52-week randomized trial of clozapine vs chlorpromazine
    Jeffrey A Lieberman
    Department of Psychiatry, CB 7160, University of North Carolina School of Medicine, Chapel Hill, NC 27599 7160, USA
    Neuropsychopharmacology 28:995-1003. 2003
    ..Longer duration of untreated psychosis was associated with lower odds of achieving remission...
  11. ncbi request reprint The subject advocate: protecting the interests of participants with fluctuating decisionmaking capacity
    Scott Stroup
    University of North Carolina School of Medicine, USA
    IRB 25:9-11. 2003
  12. ncbi request reprint Concealed medicines for people with schizophrenia: a U.S. perspective
    Scott Stroup
    Department of Psychiatry, The University of North Carolina School of Medicine, Chapel Hill 27599 7160, USA
    Schizophr Bull 28:537-42. 2002

Research Grants1

  1. Addressing Challenges in Schizophrenia Research
    THOMAS STROUP; Fiscal Year: 2007
    ..The applicant's career will focus on designing and testing interventions to improve outcomes of persons who are severely affected by schizophrenia. ..